Taigen Biopharmaceutica (Taiwan) Market Value
| 4157 Stock | TWD 11.45 0.35 2.97% |
| Symbol | Taigen |
Taigen Biopharmaceutica 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Taigen Biopharmaceutica's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Taigen Biopharmaceutica.
| 11/15/2024 |
| 12/15/2024 |
If you would invest 0.00 in Taigen Biopharmaceutica on November 15, 2024 and sell it all today you would earn a total of 0.00 from holding Taigen Biopharmaceuticals Holdings or generate 0.0% return on investment in Taigen Biopharmaceutica over 30 days. Taigen Biopharmaceutica is related to or competes with Apex Biotechnology, Ruentex Development, WiseChip Semiconductor, Novatek Microelectronics, Leader Electronics, Advanced Ceramic, and Information Technology. More
Taigen Biopharmaceutica Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Taigen Biopharmaceutica's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Taigen Biopharmaceuticals Holdings upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.27) | |||
| Maximum Drawdown | 9.62 | |||
| Value At Risk | (2.39) | |||
| Potential Upside | 2.08 |
Taigen Biopharmaceutica Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Taigen Biopharmaceutica's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Taigen Biopharmaceutica's standard deviation. In reality, there are many statistical measures that can use Taigen Biopharmaceutica historical prices to predict the future Taigen Biopharmaceutica's volatility.| Risk Adjusted Performance | (0.14) | |||
| Jensen Alpha | (0.30) | |||
| Total Risk Alpha | (0.51) | |||
| Treynor Ratio | 1.29 |
Taigen Biopharmaceutica Backtested Returns
Taigen Biopharmaceutica owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.23, which indicates the firm had a -0.23% return per unit of risk over the last 3 months. Taigen Biopharmaceuticals Holdings exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Taigen Biopharmaceutica's Variance of 2.31, risk adjusted performance of (0.14), and Coefficient Of Variation of (484.32) to confirm the risk estimate we provide. The entity has a beta of -0.25, which indicates not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Taigen Biopharmaceutica are expected to decrease at a much lower rate. During the bear market, Taigen Biopharmaceutica is likely to outperform the market. At this point, Taigen Biopharmaceutica has a negative expected return of -0.35%. Please make sure to validate Taigen Biopharmaceutica's standard deviation, total risk alpha, and the relationship between the coefficient of variation and jensen alpha , to decide if Taigen Biopharmaceutica performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.13 |
Insignificant predictability
Taigen Biopharmaceuticals Holdings has insignificant predictability. Overlapping area represents the amount of predictability between Taigen Biopharmaceutica time series from 15th of November 2024 to 30th of November 2024 and 30th of November 2024 to 15th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Taigen Biopharmaceutica price movement. The serial correlation of 0.13 indicates that less than 13.0% of current Taigen Biopharmaceutica price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.13 | |
| Spearman Rank Test | 0.22 | |
| Residual Average | 0.0 | |
| Price Variance | 0.06 |
Taigen Biopharmaceutica lagged returns against current returns
Autocorrelation, which is Taigen Biopharmaceutica stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Taigen Biopharmaceutica's stock expected returns. We can calculate the autocorrelation of Taigen Biopharmaceutica returns to help us make a trade decision. For example, suppose you find that Taigen Biopharmaceutica has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Taigen Biopharmaceutica regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Taigen Biopharmaceutica stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Taigen Biopharmaceutica stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Taigen Biopharmaceutica stock over time.
Current vs Lagged Prices |
| Timeline |
Taigen Biopharmaceutica Lagged Returns
When evaluating Taigen Biopharmaceutica's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Taigen Biopharmaceutica stock have on its future price. Taigen Biopharmaceutica autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Taigen Biopharmaceutica autocorrelation shows the relationship between Taigen Biopharmaceutica stock current value and its past values and can show if there is a momentum factor associated with investing in Taigen Biopharmaceuticals Holdings.
Regressed Prices |
| Timeline |
Pair Trading with Taigen Biopharmaceutica
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Taigen Biopharmaceutica position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Taigen Biopharmaceutica will appreciate offsetting losses from the drop in the long position's value.Moving against Taigen Stock
| 0.88 | 2881A | Fubon Financial Holding | PairCorr |
| 0.83 | 2891 | CTBC Financial Holding | PairCorr |
| 0.81 | 2891B | CTBC Financial Holding | PairCorr |
| 0.73 | 2882B | Cathay Financial Holding | PairCorr |
| 0.46 | 2882A | Cathay Financial Holding | PairCorr |
The ability to find closely correlated positions to Taigen Biopharmaceutica could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Taigen Biopharmaceutica when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Taigen Biopharmaceutica - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Taigen Biopharmaceuticals Holdings to buy it.
The correlation of Taigen Biopharmaceutica is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Taigen Biopharmaceutica moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Taigen Biopharmaceutica moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Taigen Biopharmaceutica can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Taigen Stock Analysis
When running Taigen Biopharmaceutica's price analysis, check to measure Taigen Biopharmaceutica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Taigen Biopharmaceutica is operating at the current time. Most of Taigen Biopharmaceutica's value examination focuses on studying past and present price action to predict the probability of Taigen Biopharmaceutica's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Taigen Biopharmaceutica's price. Additionally, you may evaluate how the addition of Taigen Biopharmaceutica to your portfolios can decrease your overall portfolio volatility.